Skip to main content

Table 3 Main clinical characteristics of the study population

From: Budd-Chiari syndrome: epidemiological and clinical characteristics of a case series in Northwest Spain

  Sex Age Risk factor Course Hb (g/dL) Platelets (x109/L) Fg (mg/dL) Alb (g/dL) TBIL (mg/dL) Anticoagulation Intervention Outcome
1 Male 68 Suspected polycythaemia vera, not confirmed Acute hepatitis 19.9 205 294 3.0 9.7 LMWH TIPS Died
2 Male 54 Multiple myeloma Acute hepatitis 10.2 81 608 3.0 2.8 None Mechanical thrombectomy Died
3 Male 39 Paroxysmal nocturnal haemoglobinuria Subacute hepatitis 9.7 66 427 NA 2.1 LMWH TIPS Survived
4 Male 21 Leukaemia Acute hepatitis 15.8 196 301 4.2 1.1 UH Mechanical thrombectomy Died
5 Female 78 Hepatocarcinoma Cirrhosis 12.5 105 325 2.9 0.8 None None Died
6 Female 84 Cirrhosis Cirrhosis 9.6 119 335 2.4 1.4 LMWHa None Died
7 Female 43 Ovarian cancer Acute hepatitis 9.3 206 511 2.7 1.1 LMWH None Survived
8 Female 73 Liver abscess Subacute hepatitis 12.1 184 NA 3.3 0.6 LMWH None Survived
9 Male 27 Not identified Subacute hepatitis 13.9 169 450 4.3 2.0 LMWH None Survived, developed cirrhosis
10 Female 39 Factor V Leiden mutation Subacute hepatitis 13.5 226 407 4.6 0.4 None None Survived
11 Female 79 Liver abscess Subacute hepatitis 10.2 464 333 3.3 1.7 LMWH None Died
12 Male 75 Colorectal cancer Acute hepatitis 10.2 194 676 2.3 0.9 LMWH None Died
13 Female 29 Antiphospholipid syndrome and systemic lupus erythematosus Subacute hepatitis 8.9 81 568 3.0 0.3 LMWHa None Survived
14 Male 51 Colorectal cancer and liver abscess Subacute hepatitis 11.6 726 715 2.7 0.6 LMWH None Survived
15 Male 49 Liver abscess Subacute hepatitis 12.4 299 465 3.4 0.7 LMWH None Survived
  1. Hb, haemoglobin; Fg, fibrinogen; Alb, albumin; TBIL, total bilirubin; LMWH, low molecular weight heparin; UF, unfractionated heparin; TIPSS, transjugular intrahepatic portosystemic shunt
  2. aTransition to acenocoumarin after 2 weeks of LMWH